Related Experiment Video
Updated: Mar 7, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Differences in Age-distribution, Oncological Diagnoses and Stage in Roma and Non-Roma Cancer Patients Registered at
Background:
Roma (Gypsies) constitute the largest ethnic minority in Slovakia. Although some studies have reported a higher prevalence of communicable diseases in Roma, there have been no studies on cancer prevalence in Roma. The aim of this study was to compare differences in age at diagnosis, oncological diagnoses, and stage between Roma and non-Roma patients registered at a single oncology outpatient department in Eastern Slovakia where substantial numbers of Roma patients are treated.
Patients And Methods:
Roma and non-Roma cancer patients were identified based on the judgement of both the treating physician and nurse. Age at diagnosis, oncology diagnoses, and disease stage were compared between Roma and non-Roma patients.
Results:
Thirty Roma and 702 non-Roma cancer patients were identified. The age distribution at diagnosis was not statistically different between Roma and non-Roma for both male and female patients. A statistically significant difference was detected in the number of Roma men having lung cancer (risk ratio - RR 0.19; 95% CI 0.13-0.35; p < 0.01), and more Roma women had kidney cancer (RR 0.16; 95% CI 0.05-0.69; p = 0.01). There were numerically more Roma patients diagnosed with TNM stage IV disease. Significantly more Roma men were diagnosed with stage IV disease than with stage I-III disease.
Conclusion:
The data suggest that differences in cancer type exist between Roma and non-Roma patients. Larger population--based studies directed at analyzing for differences between Roma and non-Roma cancer patients are warranted.Key words: Roma - neoplasms - histology - stage.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

